Archive - October 2018
Revlimid shows significant PFS improvement in smoldering multiple myeloma
Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection
UK science could be ‘crippled’ by a hard Brexit
Novartis claims a rare win at ESMO for PI3K inhibitor class
Merck’s Bavencio joins first-line kidney cancer face-off
Accelerated Access Collaborative announces first Rapid Uptake Products for NHS
A Heartbreak Can Actually Kill You
Meditation Health Effects: 5 Benefits